Belgium· BE-AMP-SAM113005-00

Lysanxia 10 mg

A prazepam product containing prazepam, registered in Belgium by Pfizer. The same ATC class is registered in 3 of our 19 countries.

ATC N05BA11

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLysanxia 10 mgATCN05BA11REGISTER NO.BE-AMP-SAM113005-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Prazepam is registered in 3 of 19 countries.

Countries holding a registration under ATC N05BA11 (prazepam), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose

Prazepam · ATC N05BA11

3 / 19 countries

  • Belgiumprice
  • Franceprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of prazepam costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Prazepam · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Prazepam
Manufacturer
Pfizer
Country
Belgium (BE)
ATC code
N05BA11
ATC class
Prazepam
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0118638
  • be_apb
    0118646

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

49 interactions on record for prazepam.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Prazepam · interactions on record

49 records

49 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Prazepam in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prazepam products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • France · Lysanxia, Prazepam Arrow
  • Italy · Prazene, Prazepam Eg
  • Luxembourg · Lysanxia, Prazepam Eg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e6c51ad3-1800-48c1-acda-ecb39962f2ca
GET /v1/drugs/e6c51ad3-1800-48c1-acda-ecb39962f2ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Lysanxia 10 mg",
  "name_fr": "Lysanxia 10 mg",
  "name_nl": "Lysanxia 10 mg",
  "amp_code": "SAM113005-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "93.7300"
  ],
  "pack_count": 2,
  "substances": [
    "Prazepam",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Prazepam",
  "authorisation_numbers": [
    "BE113005"
  ]
}

See everything about prazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.